Provided by Tiger Trade Technology Pte. Ltd.

Fractyl Health

0.4501
-0.0943-17.32%
Post-market: 0.4500-0.0001-0.02%19:59 EDT
Volume:5.55M
Turnover:2.51M
Market Cap:71.41M
PE:-0.40
High:0.5142
Open:0.5004
Low:0.4253
Close:0.5444
52wk High:2.45
52wk Low:0.3772
Shares:158.65M
Float Shares:128.00M
Volume Ratio:2.76
T/O Rate:4.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1193
EPS(LYR):-1.8600
ROE:-778.33%
ROA:-74.57%
PB:-42.89
PE(LYR):-0.24

Loading ...

Fractyl Health - 33% of Patients Continued to Lose Weight One Year After Glp-1 Discontinuation

THOMSON REUTERS
·
Jun 04

Fractyl Health - No Procedure-Related Serious Adverse Events Observed With Revita

THOMSON REUTERS
·
Jun 04

Fractyl Health - Mean Weight Change of 5.3% Observed With Revita at One Year

THOMSON REUTERS
·
Jun 04

Fractyl Health Reports Positive One-Year Reveal-1 Open-Label Results Showing Sustained Post-Glp-1 Weight Maintenance After a Single Revita® Procedure

THOMSON REUTERS
·
Jun 04

Fractyl Health names Mike Zumdahl SVP of market access, commercial strategy

Reuters
·
Jun 01

Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy

THOMSON REUTERS
·
Jun 01

Fractyl Health’s Pivotal Year: Inside the Earnings Call

TIPRANKS
·
May 14

Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), UnitedHealth (UNH) and TELA Bio (TELA)

TIPRANKS
·
May 13

Fractyl Health reports Q1 EPS 6c, consensus (16c)

TIPRANKS
·
May 13

BRIEF-Fractyl Health Reports First Quarter 2026 Financial Results

Reuters
·
May 13

Fractyl Health Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Fractyl Health Q1 EPS $0.06 Beats $(0.16) Estimate

Benzinga Earnings
·
May 13

Fractyl Health Q1 FY26 turns to net income of $9.22 million; operating loss narrows 15.9% to $20.82 million

Reuters
·
May 13

Fractyl Health Inc - Reiterates Cash Runway Guidance Into Early 2027

THOMSON REUTERS
·
May 13

Fractyl Health Inc: Q1 EPS $0.06

THOMSON REUTERS
·
May 13

Press Release: Fractyl Health Reports First Quarter 2026 Financial Results and Business Updates

Dow Jones
·
May 13

Fractyl Health wins Dutch clearance to start RJVA-001 first-in-human trial

Reuters
·
May 11

Fractyl Health Inc - Plans Rjva-001 Study in Australia; Regulatory Feedback Expected Q3 2026

THOMSON REUTERS
·
May 11

Fractyl Health Authorized to Initiate First-in-Human Trial of Rjva-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes

THOMSON REUTERS
·
May 11

Fractyl Health Inc - First Patient Dosing and Preliminary Data for Rjva-001 Expected in H2 2026

THOMSON REUTERS
·
May 11